Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edwin P Alyea

Showing results (141-150 of 176) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|October 7, 2016
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphomaAlex F Herrera, Haesook T Kim, Katherine A Kong, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Bone Marrow Transplantation|October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationZachariah DeFilipp, Shuli Li, David Avigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L Scott, Marcelo C Pasquini, Brent R Logan, et al.
Bone Marrow Transplantation|April 4, 2026
Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairmentMatthew A Bergens, Matthew Braun, Ernaya J Johnson, et al.
Blood Advances|November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trialVincent T Ho, Haesook T Kim, Jennifer Brock, et al.
Pageof 18

Showing results (141-150 of 176) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|October 7, 2016
Next-generation sequencing-based detection of circulating tumour DNA After allogeneic stem cell transplantation for lymphomaAlex F Herrera, Haesook T Kim, Katherine A Kong, et al.
Blood|April 14, 2016
Efficacy, durability, and response predictors of low-dose interleukin-2 therapy for chronic graft-versus-host diseaseJohn Koreth, Haesook T Kim, Kyle T Jones, et al.
Blood|February 14, 2018
α<sub>1</sub>-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host diseaseJohn M Magenau, Steven C Goldstein, Dan Peltier, et al.
Haematologica|January 13, 2018
Bortezomib-based immunosuppression after reduced-intensity conditioning hematopoietic stem cell transplantation: randomized phase II resultsJohn Koreth, Haesook T Kim, Paulina B Lange, et al.
Blood Advances|April 3, 2019
Efficacy and immunologic effects of extracorporeal photopheresis plus interleukin-2 in chronic graft-versus-host diseaseRoger Belizaire, Haesook T Kim, Samuel J Poryanda, et al.
Blood Advances|May 7, 2020
BK virus-specific T-cell immune reconstitution after allogeneic hematopoietic cell transplantationEduardo Espada, Matthew P Cheng, Haesook T Kim, et al.
Bone Marrow Transplantation|October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiationZachariah DeFilipp, Shuli Li, David Avigan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2017
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic SyndromesBart L Scott, Marcelo C Pasquini, Brent R Logan, et al.
Bone Marrow Transplantation|April 4, 2026
Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairmentMatthew A Bergens, Matthew Braun, Ernaya J Johnson, et al.
Blood Advances|November 22, 2021
GM-CSF secreting leukemia cell vaccination for MDS/AML after allogeneic HSCT: a randomized, double-blinded, phase 2 trialVincent T Ho, Haesook T Kim, Jennifer Brock, et al.
Pageof 18